Anti-Matrix protein 1 antibody [GA2B] (ab22396)
Key features and details
- Mouse monoclonal [GA2B] to Matrix protein 1
- Suitable for: Flow Cyt, IHC-P, WB, ICC/IF
- Reacts with: Influenza A
- Isotype: IgG1
Overview
-
Product name
Anti-Matrix protein 1 antibody [GA2B]
See all Matrix protein 1 primary antibodies -
Description
Mouse monoclonal [GA2B] to Matrix protein 1 -
Host species
Mouse -
Tested applications
Suitable for: Flow Cyt, IHC-P, WB, ICC/IFmore details -
Species reactivity
Reacts with: Influenza A -
Immunogen
Tissue, cells or virus corresponding to Matrix protein 1. Influenza A/ Puerto Rico/ 8/ 34 (H1N1) and A/Bangkok/ 1/ 79 (H3N2) viruses
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
Storage buffer
pH: 7.50
Preservative: 0.09% Sodium azide
Constituent: PBS -
Concentration information loading...
-
Purity
SDS-PAGE -
Purification notes
>90% IgG content as established by SDS PAGE -
Clonality
Monoclonal -
Clone number
GA2B -
Myeloma
P3x63-Ag8.653 -
Isotype
IgG1 -
Research areas
Images
-
Immunocytochemistry/ Immunofluorescence - Anti-Matrix protein 1 antibody [GA2B] (ab22396) Image from Chase GP et al., PLoS Pathog. 2011 Sep;7(9):e1002187. Epub 2011 Sep 1.Fig 4.; doi:10.1371/journal.ppat.1002187; September 1, 2011, PLoS Pathog 7(9): e1002187.Immunofluorescence analysis of HeLa cells staining Influenza A Virus M1 using ab22396.
Cells were treated with either 20 µg/ml Prostaglandin A (PGA) or EtOH vehicle control, 3 hours post infection by Influenza A Virus, then fractionated at 9 hours post infection before analysis by immunofluorescence.